Preclinical CRO Market Size, Share & COVID-19 Impact Analysis, By Type (Drug Metabolism and Pharmacokinetics (DMPK), Bioanalysis, Toxicology Studies, and Safety Services), By Application (Oncology, Neurology, Cardiology, Infectious Diseases, Metabolic Disorders, and Others), By End-user (Pharmaceutical & Biotechnological Companies, Academic & Research Institutes, and Others), and Regional Forecast, 2026-2034

Last Updated: March 09, 2026 | Format: PDF | Report ID: FBI106939

We will customize the report to meet your research goals, helping you gain a competitive edge, and make informed decisions.

Schedule a 30 minutes session to understand our consulting capabilities – SCHEDULE NOW

Table of Content

Introduction
1. Research Scope
2. Market Segmentation
3. Research Methodology
4. Definitions and Assumptions
Executive Summary
Market Dynamics
1. Market Drivers
2. Market Restraints
3. Market Opportunities
4. Market Trends
Key Insights
1. Number of Preclinical Trials Conducted – by Key Countries/ Regions, 2025
2. R&D Investment – by Key Players
3. Key Industry Developments (Mergers, Acquisitions, Partnerships, etc.)
4. Impact of COVID-19 on the Market
Global Preclinical CRO Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Type
  1. Drug Metabolim and Pharmacokinetics (DMPK)
  2. Bioanalysis
  3. Toxicology Studies
  4. Safety Services
2. Market Analysis, Insights and Forecast – By Application
  1. Oncology
  2. Neurology
  3. Cardiology
  4. Infectious Disease
  5. Metabolic Disorder
  6. Others
3. Market Analysis, Insights and Forecast – By End-user
  1. Pharmaceutical & Biotechnological Companies
  2. Academic & Government Research Institutes
  3. Others
4. Market Analysis, Insights and Forecast – By Region
  1. North America
  2. Europe
  3. Asia pacific
  4. Rest of the World
North America Preclinical CRO Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Type
  1. Drug Metabolim and Pharmacokinetics (DMPK)
  2. Bioanalysis
  3. Toxicology Studies
  4. Safety Services
2. Market Analysis, Insights and Forecast – By Application
  1. Oncology
  2. Neurology
  3. Cardiology
  4. Infectious Disease
  5. Metabolic Disorder
  6. Others
3. Market Analysis, Insights and Forecast – By End-user
  1. Pharmaceutical & Biotechnological Companies
  2. Academic & Government Research Institutes
  3. Others
4. Market Analysis – By Country
  1. U.S.
  2. Canada
Europe Preclinical CRO Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Type
  1. Drug Metabolim and Pharmacokinetics (DMPK)
  2. Bioanalysis
  3. Toxicology Studies
  4. Safety Services
2. Market Analysis, Insights and Forecast – By Application
  1. Oncology
  2. Neurology
  3. Cardiology
  4. Infectious Disease
  5. Metabolic Disorder
  6. Others
3. Market Analysis, Insights and Forecast – By End-user
  1. Pharmaceutical & Biotechnological Companies
  2. Academic & Government Research Institutes
  3. Others
4. Market Analysis – By Country/Sub-region
  1. U.K.
  2. Germany
  3. France
  4. Spain
  5. Italy
  6. Scandinavia
  7. Rest of Europe
Asia pacific Preclinical CRO Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Type
  1. Drug Metabolim and Pharmacokinetics (DMPK)
  2. Bioanalysis
  3. Toxicology Studies
  4. Safety Services
2. Market Analysis, Insights and Forecast – By Application
  1. Oncology
  2. Neurology
  3. Cardiology
  4. Infectious Disease
  5. Metabolic Disorder
  6. Others
3. Market Analysis, Insights and Forecast – By End-user
  1. Pharmaceutical & Biotechnological Companies
  2. Academic & Government Research Institutes
  3. Others
4. Market Analysis – By Country/Sub-region
  1. Japan
  2. China
  3. India
  4. Australia
  5. Southeast Asia
  6. Rest of Asia Pacific
Rest of the World Preclinical CRO Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Type
  1. Drug Metabolim and Pharmacokinetics (DMPK)
  2. Bioanalysis
  3. Toxicology Studies
  4. Safety Services
2. Market Analysis, Insights and Forecast – By Application
  1. Oncology
  2. Neurology
  3. Cardiology
  4. Infectious Disease
  5. Metabolic Disorder
  6. Others
3. Market Analysis, Insights and Forecast – By End-user
  1. Pharmaceutical & Biotechnological Companies
  2. Academic & Government Research Institutes
  3. Others
Competitive Analysis
1. Global Market Share Analysis (2025)
2. Company Profiles
  1. Novotech
    1. Overview
    2. Services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  2. Thermo Fisher Scientific Inc.
    1. Overview
    2. Services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  3. Medpace
    1. Overview
    2. Services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  4. Icon plc
    1. Overview
    2. Services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  5. Syneos Health
    1. Overview
    2. Services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  6. Eurofins Discovery
    1. Overview
    2. Services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  7. EVOTEC
    1. Overview
    2. Services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  8. Charles River Laboratories
    1. Overview
    2. Services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  9. WuXi AppTec
    1. Overview
    2. Services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)

Introduction
1. Research Scope
2. Market Segmentation
3. Research Methodology
4. Definitions and Assumptions
Executive Summary
Market Dynamics
1. Market Drivers
2. Market Restraints
3. Market Opportunities
4. Market Trends
Key Insights
1. Number of Preclinical Trials Conducted – by Key Countries/ Regions, 2025
2. R&D Investment – by Key Players
3. Key Industry Developments (Mergers, Acquisitions, Partnerships, etc.)
4. Impact of COVID-19 on the Market
Global Preclinical CRO Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Type
  1. Drug Metabolim and Pharmacokinetics (DMPK)
  2. Bioanalysis
  3. Toxicology Studies
  4. Safety Services
2. Market Analysis, Insights and Forecast – By Application
  1. Oncology
  2. Neurology
  3. Cardiology
  4. Infectious Disease
  5. Metabolic Disorder
  6. Others
3. Market Analysis, Insights and Forecast – By End-user
  1. Pharmaceutical & Biotechnological Companies
  2. Academic & Government Research Institutes
  3. Others
4. Market Analysis, Insights and Forecast – By Region
  1. North America
  2. Europe
  3. Asia pacific
  4. Rest of the World
North America Preclinical CRO Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Type
  1. Drug Metabolim and Pharmacokinetics (DMPK)
  2. Bioanalysis
  3. Toxicology Studies
  4. Safety Services
2. Market Analysis, Insights and Forecast – By Application
  1. Oncology
  2. Neurology
  3. Cardiology
  4. Infectious Disease
  5. Metabolic Disorder
  6. Others
3. Market Analysis, Insights and Forecast – By End-user
  1. Pharmaceutical & Biotechnological Companies
  2. Academic & Government Research Institutes
  3. Others
4. Market Analysis – By Country
  1. U.S.
  2. Canada
Europe Preclinical CRO Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Type
  1. Drug Metabolim and Pharmacokinetics (DMPK)
  2. Bioanalysis
  3. Toxicology Studies
  4. Safety Services
2. Market Analysis, Insights and Forecast – By Application
  1. Oncology
  2. Neurology
  3. Cardiology
  4. Infectious Disease
  5. Metabolic Disorder
  6. Others
3. Market Analysis, Insights and Forecast – By End-user
  1. Pharmaceutical & Biotechnological Companies
  2. Academic & Government Research Institutes
  3. Others
4. Market Analysis – By Country/Sub-region
  1. U.K.
  2. Germany
  3. France
  4. Spain
  5. Italy
  6. Scandinavia
  7. Rest of Europe
Asia pacific Preclinical CRO Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Type
  1. Drug Metabolim and Pharmacokinetics (DMPK)
  2. Bioanalysis
  3. Toxicology Studies
  4. Safety Services
2. Market Analysis, Insights and Forecast – By Application
  1. Oncology
  2. Neurology
  3. Cardiology
  4. Infectious Disease
  5. Metabolic Disorder
  6. Others
3. Market Analysis, Insights and Forecast – By End-user
  1. Pharmaceutical & Biotechnological Companies
  2. Academic & Government Research Institutes
  3. Others
4. Market Analysis – By Country/Sub-region
  1. Japan
  2. China
  3. India
  4. Australia
  5. Southeast Asia
  6. Rest of Asia Pacific
Rest of the World Preclinical CRO Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Type
  1. Drug Metabolim and Pharmacokinetics (DMPK)
  2. Bioanalysis
  3. Toxicology Studies
  4. Safety Services
2. Market Analysis, Insights and Forecast – By Application
  1. Oncology
  2. Neurology
  3. Cardiology
  4. Infectious Disease
  5. Metabolic Disorder
  6. Others
3. Market Analysis, Insights and Forecast – By End-user
  1. Pharmaceutical & Biotechnological Companies
  2. Academic & Government Research Institutes
  3. Others
Competitive Analysis
1. Global Market Share Analysis (2025)
2. Company Profiles
  1. Novotech
    1. Overview
    2. Services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  2. Thermo Fisher Scientific Inc.
    1. Overview
    2. Services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  3. Medpace
    1. Overview
    2. Services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  4. Icon plc
    1. Overview
    2. Services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  5. Syneos Health
    1. Overview
    2. Services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  6. Eurofins Discovery
    1. Overview
    2. Services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  7. EVOTEC
    1. Overview
    2. Services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  8. Charles River Laboratories
    1. Overview
    2. Services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  9. WuXi AppTec
    1. Overview
    2. Services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)

Read Less

List of Figures

Figure 1: Global Preclinical CRO Market Revenue Breakdown (USD billion, %) by Region, 2025 & 2034

Figure 2: Global Preclinical CRO Market Value Share (%), by Type, 2025 & 2034

Figure 3: Global Preclinical CRO Market Value Share (%), by Application, 2025 & 2034

Figure 4: Global Preclinical CRO Market Value Share (%), by End-user, 2025 & 2034

Figure 5: Global Preclinical CRO Market Value (USD billion), by Region, 2025 & 2034

Figure 6: North America Preclinical CRO Market Value (USD billion), by Type, 2025 & 2034

Figure 7: North America Preclinical CRO Market Value Share (%), by Type, 2025

Figure 8: North America Preclinical CRO Market Value (USD billion), by Application, 2025 & 2034

Figure 9: North America Preclinical CRO Market Value Share (%), by Application, 2025

Figure 10: North America Preclinical CRO Market Value (USD billion), by End-user, 2025 & 2034

Figure 11: North America Preclinical CRO Market Value Share (%), by End-user, 2025

Figure 12: North America Preclinical CRO Market Value (USD billion), By Country, 2025 & 2034

Figure 13: North America Preclinical CRO Market Value Share (%), By Country, 2025

Figure 14: Europe Preclinical CRO Market Value (USD billion), by Type, 2025 & 2034

Figure 15: Europe Preclinical CRO Market Value Share (%), by Type, 2025

Figure 16: Europe Preclinical CRO Market Value (USD billion), by Application, 2025 & 2034

Figure 17: Europe Preclinical CRO Market Value Share (%), by Application, 2025

Figure 18: Europe Preclinical CRO Market Value (USD billion), by End-user, 2025 & 2034

Figure 19: Europe Preclinical CRO Market Value Share (%), by End-user, 2025

Figure 20: Europe Preclinical CRO Market Value (USD billion), By Country/ Sub-region, 2025 & 2034

Figure 21: Europe Preclinical CRO Market Value Share (%), By Country/ Sub-region, 2025

Figure 22: Asia Pacific Preclinical CRO Market Value (USD billion), by Type, 2025 & 2034

Figure 23: Asia Pacific Preclinical CRO Market Value Share (%), by Type, 2025

Figure 24: Asia Pacific Preclinical CRO Market Value (USD billion), by Application, 2025 & 2034

Figure 25: Asia Pacific Preclinical CRO Market Value Share (%), by Application, 2025

Figure 26: Asia Pacific Preclinical CRO Market Value (USD billion), by End-user, 2025 & 2034

Figure 27: Asia Pacific Preclinical CRO Market Value Share (%), by End-user, 2025

Figure 28: Asia Pacific Preclinical CRO Market Value (USD billion), By Country/ Sub-region, 2025 & 2034

Figure 29: Asia Pacific Preclinical CRO Market Value Share (%), By Country/ Sub-region, 2025

Figure 30: Rest of the World Preclinical CRO Market Value (USD billion), by Type, 2025 & 2034

Figure 31: Rest of the World Preclinical CRO Market Value Share (%), by Type, 2025

Figure 32: Rest of the World Preclinical CRO Market Value (USD billion), by Application, 2025 & 2034

Figure 33: Rest of the World Preclinical CRO Market Value Share (%), by Application, 2025

Figure 34: Rest of the World Preclinical CRO Market Value (USD billion), by End-user, 2025 & 2034

Figure 35: Rest of the World Preclinical CRO Market Value Share (%), by End-user, 2025

Figure 36: Global Preclinical CRO Market Share (%), By Company, 2025

List of Tables

Table 01: Global Preclinical CRO Market Revenue (USD billion) Forecast, by Type, 2021-2034

Table 02: Global Preclinical CRO Market Revenue (USD billion) Forecast, by Application, 2021-2034

Table 03: Global Preclinical CRO Market Revenue (USD billion) Forecast, by End-user, 2021-2034

Table 04: Global Preclinical CRO Market Revenue (USD billion) Forecast, by Region, 2021-2034

Table 05: North America Preclinical CRO Market Revenue (USD billion) Forecast, by Type, 2021-2034

Table 06: North America Preclinical CRO Market Revenue (USD billion) Forecast, by Application, 2021-2034

Table 07: North America Preclinical CRO Market Revenue (USD billion) Forecast, by End-user, 2021-2034

Table 08: North America Preclinical CRO Market Revenue (USD billion) Forecast, By Country, 2021-2034

Table 09: Europe Preclinical CRO Market Revenue (USD billion) Forecast, by Type, 2021-2034

Table 10: Europe Preclinical CRO Market Revenue (USD billion) Forecast, by Application, 2021-2034

Table 11: Europe Preclinical CRO Market Revenue (USD billion) Forecast, by End-user, 2021-2034

Table 12: Europe Preclinical CRO Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034

Table 13: Asia Pacific Preclinical CRO Market Revenue (USD billion) Forecast, by Type, 2021-2034

Table 14: Asia Pacific Preclinical CRO Market Revenue (USD billion) Forecast, by Application, 2021-2034

Table 15: Asia Pacific Preclinical CRO Market Revenue (USD billion) Forecast, by End-user, 2021-2034

Table 16: Asia Pacific Preclinical CRO Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034

Table 17: Rest of the World Preclinical CRO Market Revenue (USD billion) Forecast, by Type, 2021-2034

Table 18: Rest of the World Preclinical CRO Market Revenue (USD billion) Forecast, by Application, 2021-2034

Table 19: Rest of the World Preclinical CRO Market Revenue (USD billion) Forecast, by End-user, 2021-2034

STUDY PERIOD: 2021-2034
BASE YEAR: 2025
HISTORICAL DATA: 2021-2024
NO OF PAGES: 121

Buy Now

Download Free Sample

Security Code

Get 20% Free Customization

Expand Regional and Country Coverage, Segments Analysis, Company Profiles, Competitive Benchmarking, and End-user Insights.

Growth Advisory Services

Clients

Related Reports

Get In Touch With Us

US +1 833 909 2966 ( Toll Free )

UK +44 808 502 0280 ( Toll Free )

(APAC) +91 744 740 1245
sales@fortunebusinessinsights.com